Insider · CIK 0001841088
Mary Miller
Files at ACRV (Acrivon Therapeutics, Inc.). First filing Oct 7, 2026, latest Oct 7, 2026.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
ACRV: Acrivon Therapeutics, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 15Weak | ACRVsell Acrivon Therapeutics, Inc. | $585 294 shares | -0% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 5, 2026 | ACRV Acrivon Therapeutics, Inc. | SOpen-market sale Common Stock | -294 | $1.99 | $585 | 81,715 | 5 d ago |
| Aug 14, 2025 | ACRV Acrivon Therapeutics, Inc. | FTax withholding Common Stock | -184 | $1.39 | $256 | 35,581 | Aug 18, 2025 |
| Jul 17, 2025 | ACRV Acrivon Therapeutics, Inc. | FTax withholding Common Stock | -558 | $1.32 | $737 | 35,765 | Jul 21, 2025 |
| May 14, 2025 | ACRV Acrivon Therapeutics, Inc. | FTax withholding Common Stock | -184 | $1.14 | $210 | 36,323 | May 16, 2025 |
| Apr 17, 2025 | ACRV Acrivon Therapeutics, Inc. | FTax withholding Common Stock | -558 | $1.81 | $1,010 | 36,507 | Apr 18, 2025 |
| Apr 1, 2025 | ACRV Acrivon Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +15,616 | $0.00 | $0 | 15,616 | Apr 3, 2025 |
| Mar 1, 2025 | ACRV Acrivon Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +93,693 | $0.00 | $0 | 93,693 | Mar 4, 2025 |
| Feb 14, 2025 | ACRV Acrivon Therapeutics, Inc. | FTax withholding Common Stock | -217 | $5.42 | $1,176 | 37,065 | Feb 19, 2025 |
| Jan 17, 2025 | ACRV Acrivon Therapeutics, Inc. | FTax withholding Common Stock | -659 | $5.78 | $3,809 | 37,282 | Jan 22, 2025 |
| Mar 1, 2024 | ACRV Acrivon Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +67,567 | $0.00 | $0 | 67,567 | Nov 27, 2024 |
| Nov 14, 2024 | ACRV Acrivon Therapeutics, Inc. | FTax withholding Common Stock | -184 | $7.92 | $1,457 | 37,941 | Nov 18, 2024 |
| Oct 17, 2024 | ACRV Acrivon Therapeutics, Inc. | FTax withholding Common Stock | -558 | $7.87 | $4,391 | 38,125 | Oct 21, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.